Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis-Reference-Cited by-同舟云学术

Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis

Published:2016-05-28 Issue:6 Volume:36 Page:623-630
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Staubes Britta A.¹,Metzger Nicole L.²³,Walker Seth D.⁴,Peasah Samuel K.²

Affiliation:

1. Department of Pharmacy; Ochsner Medical Center; New Orleans Louisiana

2. Department of Pharmacy; Mercer University College of Pharmacy; Atlanta Georgia

3. Department of Pharmaceutical Services; Emory University Hospital; Atlanta Georgia

4. Division of Pulmonology, Allergy, Critical Care, and Sleep Medicine; Department of Medicine; Emory University; Atlanta Georgia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference26 articles.

1. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis-the TOPIC study: a randomised controlled trial;Smyth;Lancet,2005

2. Once-daily tobramycin in the treatment of adult patients with cystic fibrosis;Whitehead;Eur Respir J,2002

3. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?;Burkhardt;J Antimicrob Chemother,2006

4. Single or multiple daily doses of aminoglycosides: a meta-analysis;Barza;BMJ,1996

5. Evaluation of serum concentrations achieved with an empiric once-daily tobramycin dosage regimen in children and adults with cystic fibrosis;Vandenbussche;J Pediatr Pharmacol Ther,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis;Therapeutic Drug Monitoring;2023-04

2. Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions;Clinical Pharmacokinetics;2021-01-24

3. Pharmacokinetic/pharmacodynamic analysis of weight- and height-scaled tobramycin dosage regimens for patients with cystic fibrosis;Journal of Antimicrobial Chemotherapy;2019-05-06

4. Amikacin target achievement in adult cystic fibrosis patients utilizing Monte Carlo simulation;Pediatric Pulmonology;2018-12-03